Merck Riled In Tax Dispute With U.S. And Canada

Law360, New York (November 8, 2006, 12:00 AM EST) -- Pharmaceutical giant Merck & Co. disclosed on Tuesday that in addition to other woes, liabilities from four tax disputes in North America could cost it a total of $5.58 billion.

Tax authorities in the United States and Canada have cracked down on Merck’s practice of “transfer pricing.” Transfer pricing relates to the practice of reporting large amounts of revenue in a low-tax jurisdiction or large amounts of expenses in a high-tax jurisdiction, thus lowering taxable income.

Merck’s filing with the Securities and Exchange Commission mentions, among...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.